Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements

Cited by (1,000)

Items 701–800 of 1,000

1. The CRISPR/Cas System: Emerging Technology and Application
   2016 · Caister Academic Press eBooks
2. Cancer diagnosis and immunotherapy in the age of CRISPR
   Peter J. Cook, Andrea Ventura · 2018 · Genes Chromosomes and Cancer
3. Multifaceted regulation of enhancers in cancer
   Qiong Xiao, Yong Xiao, Lianyun Li, Mingkai Chen, Min Wu · 2022 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
4. AP-1 Imprints a Reversible Transcriptional Program of Senescent Cells
   Ricardo Iván Martínez-Zamudio, Pierre‐François Roux, José Américo Nabuco Leva Ferreira de Freitas, Lucas J. Robinson, Grégory R G Doré, Bin Sun, Jesús Gil, Utz Herbig, Oliver Bischof · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
5. Long-lasting Analgesia via Targeted in vivo Epigenetic Repression of Nav1.7
   Ana M. Moreno, Glaucilene Ferreira Catroli, Fernando Alemán, Andrew Pla, Sarah A. Woller, Michael Y. Hu, Tony L. Yaksh, Prashant Mali · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
6. Combinatorial effector targeting (COMET) for transcriptional modulation and locus-specific biochemistry
   Caroline M. Wilson, Greg C. Pommier, Daniel D. Richman, Nicholas A. Sambold, Jeffrey A. Hussmann, Jonathan S. Weissman, Luke A. Gilbert · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
7. Beyond conventional therapies: Gut microbiota modulation and macromolecular drugs in the battle against cardiometabolic diseases
   Jingyue Wang, Jing Qu, Mengliang Ye, Ru Feng, Xiang Hui, Xinyu Yang, Jingyu Jin, Qian Tong, Xianfeng Zhang, Yan Wang · 2025 · Journal of Pharmaceutical Analysis
8. CRISPR-Cas editing technologies for viral-mediated gene therapies of human diseases: Mechanisms, progress, and challenges
   Boris Kantor, Leanne C. Duke, Pradeep G. Bhide · 2025 · Molecular Therapy — Nucleic Acids
9. Epigenetic stress memory for predictive and heritable crop epibreeding
   Mughair Abdul Aziz, Khaled Masmoudi · 2026 · Plant Stress
10. Uncovering oligodendrocyte enhancers that control Cnp expression
    Chuandong Fan, Hongjoo An, Dongkyeong Kim, Yungki Park · 2023 · Human Molecular Genetics
11. Epigenetics and alternative splicing in cancer: old enemies, new perspectives
    Madhura R. Pandkar, Sanjeev Shukla · 2024 · Biochemical Journal
12. Long Non-coding RNAs Diversity in Form and Function: From Microbes to Humans
    Gabriela Chávez‐Calvillo, Huachen Gan, Joanna Sztuba-Solińska · 2020 · RNA technologies
13. A CRISPR interference strategy for gene expression silencing in multiple myeloma cell lines
    Josep Escrivá-Fernández, Cristina Cueto‐Ureña, Amalia Solana-Orts, Elisa Lledó, Begoña Ballester‐Lurbe, Enric Poch · 2023 · Journal of Biological Engineering
14. Toward the Development of a Tissue Engineered Gradient Utilizing CRISPR-Guided Gene Modulation
    Jacob D. Weston, Brooke Austin, Hunter Levis, Jared L. Zitnay, Jeffrey A. Weiss, Brandon Douglas Lawrence, Robby D. Bowles · 2024 · Tissue Engineering Part A
15. Use of CRISPRoff and synthetic Notch to modulate and relay endogenous gene expression programs in engineered cells
    Shu-qun Shi, Catherine A. Hamann, Joanne C. Lee, Jonathan M. Brunger · 2024 · Frontiers in Bioengineering and Biotechnology
16. KLF4 Promotes a KRT13+ Hillock-Like State in Lung Squamous Cell Carcinoma
    Luke Izzo, Tony Reyes, Srijan Meesala, Abbie S. Ireland, Lisa B. Earnest-Noble, S S Yang, Hari Shankar Sunil, Xiao Chun Cheng, Nomi Tserentsoodol, Sarah B. Hawgood et al. · 2026 · Cancer Research
17. Re-structuring lentiviral vectors to express genomic RNA via cap-dependent translation
    John Robert Counsell, Guillaume De Brabandere, Rajvinder Karda, Marc Moore, Antonio Greco, Alysha Bray, Juan F. Antinao Diaz, Dany P.B. Perocheau, Ulrike Mock, Simon N. Waddington · 2020 · Molecular Therapy — Methods & Clinical Development
18. Gene delivery in adherent and suspension cells using the combined physical methods
    Kimia Kardani, Alireza Milani, Azam Bolhassani · 2022 · Cytotechnology
19. Advances in genetic engineering of domestic animals
    Shaohua WANG, Kun ZHANG, Yunping DAI · 2016 · Frontiers of Agricultural Science and Engineering
20. Nuclease-dead S. aureus Cas9 downregulates alpha-synuclein and reduces mtDNA damage and oxidative stress levels in patient-derived stem cell model of Parkinson’s disease
    Danuta Sastre, Faria Zafar, C. Alejandra Morato Torres, Desiree Piper, Deniz Kirik, Laurie H. Sanders, Lei S. Qi, Birgitt Schüle · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
21. Robust nuclease-dead S. aureus dCas9-mediated alpha-synuclein knockdown in substantia nigra in a humanized mouse model of Parkinson’s disease
    C. Alejandra Morato Torres, Faria Zafar, Danuta Sastre, De’Angelo Hermesky, Max Yang Chen, Jocelyn Palafox Vazquez, Lei S. Qi, Deniz Kirik, Birgitt Schüle · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
22. A systematic survey of distal element-gene regulatory interactions with Direct-Capture Targeted Perturb-seq
    Judhajeet Ray, Evelyn Jagoda, Maya U. Sheth, James Galante, Dulguun Amgalan, Eugenio Mattei, Andreas R. Gschwind, Chad J. Munger, Jacob Huang, Glen Munson et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
23. Interrogating the Regulatory Function of HAQERs during Human Cortical Development
    Yashodara Abeykoon, Natalie Dzikowski, Yanting Luo, Enakshi Sinniah, Seth Weaver, Bryan J. Pavlovic, Jenelle L. Wallace, Riley J. Mangan, Craig B. Lowe, Alex A. Pollen · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
24. The clinical use of epigenetics in psychiatry: a narrative review of epigenetic mechanisms, key candidate genes, and precision psychiatry
    Montel Hayes, Rachel, Mason, Christopher E., Miller, John J. · 2025 · Frontiers in Psychiatry
25. Emerging nucleases in crop genome editing: towards intellectual property independence and technical flexibility
    Wenxin Lin, Li Chen, Meina Li, Yuefeng Guan · 2025 · Seed Biology
26. MEF2D-expressing cancer precursors reprogram tissue-resident macrophages to support liver tumorigenesis
    Jun-Yu Xiang, Y. Ni, Jiajun Yu, Hui Sun, Zhiyun Gu, Ziyong Li, Tongwang Yang, Juan Feng, Li Su, Li-Mei Liu et al. · 2025 · Nature Cancer
27. Therapeutic precision gene editing of cholesterol pathways as a gene therapy strategy for cardiovascular disease
    Ezgi Erbasan, Melike Aliciaslan, Fulya Erendor, Ahter Dilşad Şanlioğlu, Salih Şanlıoğlu · 2025 · Gene Therapy
28. CRISPR and gene editing technologies for bleeding disorders
    Thierry VandenDriessche, Mathias Janssens, Marinee Chuah · 2025 · Therapeutic Advances in Hematology
29. Re-engineered guide RNA enables DNA loops and contacts modulating repression in E. coli
    Yunshi Yang, Iris Rocamonde-Lago, Boxuan Shen, Ieva Berzina, Johanna Zipf, Björn Högberg · 2024 · Nucleic Acids Research
30. A Practical Guide to Genome Editing Using Targeted Nuclease Technologies
    Shaina N. Porter, Rachel M. Levine, S. Pruett-Miller · 2019 · Comprehensive Physiology
31. Engineering CRISPR for emerging therapeutic applications
    Xiaoqi Sun, Zhuang Liu · 2024 · EngMedicine
32. Enhancers and genome conformation provide complex transcriptional control of a herpesviral gene
    David W. Morgens, Leah Gulyas, Xiaowen Mao, Alejandro Rivera-Madera, Annabelle S Souza, Britt A. Glaunsinger · 2024 · Molecular Systems Biology
33. Retrospect and prospect: reproductive technologies in beef cattle
    Zhiqiang Li, Hongyu Liu, Jun Wang, Yang Zhou, Yi Fang, Wenfa Lu · 2025 · Molecular Biology Reports
34. Perspectives on the use of the CRISPR system in plants to improve recombinant therapeutic protein production
    Edgar Trujillo, Carlos Angulo · 2025 · Journal of Biotechnology
35. Designing Epigenome Editors: Considerations of Biochemical and Locus Specificities
    Dilara Sen, Albert J. Keung · 2018 · Methods in molecular biology
36. Notes on Functional Modules in the Assembly of CRISPR/Cas9-Mediated Epigenetic Modifiers
    Alexander V. Kondrashov, Elena Karpova · 2020 · Methods in molecular biology
37. A unifying statistical framework to discover disease genes from GWASs
    Justin N.J. McManus, Robert J. Lovelett, Daniel Lowengrub, Sarah Christensen · 2023 · Cell Genomics
38. UBE2C promotes leptomeningeal dissemination and is a therapeutic target in brain metastatic disease
    Eunice Paisana, Rita Cascão, Carlos Custódia, Nan Qin, Daniel J. Picard, David Pauck, Tânia Carvalho, Pedro Ruivo, Clara Barreto, Delfim Doutel et al. · 2023 · Neuro-Oncology Advances
39. Applications of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) as a Genetic Scalpel for the Treatment of Cancer: A Translational Narrative Review
    Riddhi Mondal, Niki Brahmbhatt, Sahibjot K Sandhu, Hetvi Shah, Mandeepsinh Vashi, Siddharth Kamal Gandhi, Priyansh Patel · 2023 · Cureus
40. Recruitment of transcriptional effectors by Cas9 creates cis-regulatory elements and demonstrates distance-dependent transcriptional regulation
    Jubran Boulos, Arkadiy K. Golov, Nadav Keren, Itai Erlich, Nardeen Shehadeh, Nili Avidan, Hagai Kariti, Omer Sadeh, Lilac Haimovich-Caspi, Adam S. Helms et al. · 2025 · iScience
41. DNA Methylation: Basic Principles
    Cynthia A. Moylan, Susan K. Murphy · 2016 · Elsevier eBooks
42. Shaping the nebulous enhancer in the era of high-throughput assays and genome editing
    Edwin Yu-Kiu Ho, Qin Cao, Mengting Gu, Ricky Wai-Lun Chan, Qiong Wu, Mark Gerstein, Kevin Yuk-Lap Yip · 2019 · Briefings in Bioinformatics
43. Dead Cas Systems: Types, Principles, and Applications
    Sergey Brezgin, Anastasiya Kostyusheva, Dmitry S. Kostyushev, Vladimir Chulanov · 2020 · Vide Leaf, Hyderabad eBooks
44. New tools for experimental diabetes research: Cellular reprogramming and genome editing
    Timo Otonkoski · 2016 · Upsala Journal of Medical Sciences
45. crisprQTL mapping as a genome-wide association framework for cellular genetic screens
    Molly J. Gasperini, Andrew J. Hill, José L. McFaline‐Figueroa, Beth Martin, Cole Trapnell, Nadav Ahituv, Jay Shendure · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
46. CRISPR interference at the FAAH-OUT genomic region reduces FAAH expression
    Hajar Mikaeili, Charlix Yeung, Abdella M. Habib, John N. Wood, Andrei L. Okorokov, James J. Cox · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
47. Lineage specific transcription factor waves reprogram neuroblastoma from self-renewal to differentiation
    Deblina Banerjee, Berkley E. Gryder, Sukriti Bagchi, Zhihui Liu, Hsien-Chao Chen, Man Xu, Ming Sun, Zalman Vaksman, Sharon J. Diskin, Javed Iqbal Khan et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
48. Genome-wide CRISPR interference screen identifies long non-coding RNA loci required for differentiation and pluripotency
    Jeffrey R. Haswell, Kaia Mattioli, Chiara Gerhardinger, Philipp G. Maass, Daniel J. Foster, Paola P. Fernandez, Xiaofeng Wang, John L. Rinn, Frank John Slack · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
49. CRISPR‐Cas9 System for Agriculture Crop Improvement
    Ashish Sharma, Poorwa Kamal Badola, Prabodh Kumar Trivedi · 2021
50. Quantitative dialing of gene expression via precision targeting of KRAB repressor
    Matthew S. Wilken, Christie Ciarlo, Jocelynn R. Pearl, Elaine V. Schanzer, Hanna Liao, Benjamin P. Van Biber, Konstantin Queitsch, Jordan E. Bloom, Alexander Joel Federation, Reyes Acosta et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
51. A modular dCas9-based recruitment platform for combinatorial epigenome editing
    Tessa Swain, Christian Pflueger, Saskia Freytag, Daniel Poppe, Jahnvi Pflueger, Trung Viet Nguyen, Ji Kevin Li, Ryan Lister · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
52. RNA renaissance: Harnessing non-coding RNA therapeutics for hepatocellular carcinoma
    Subhas Das, Soumyabrata Chatterjee, Tushar C. Patel, Soma Banerjee · 2025 · Pharmacology & Therapeutics
53. Segmentally Duplicated Regulatory Elements Undergo Human-Specific Rewiring
    Seth Weaver, Craig B. Lowe · 2026 · Molecular Biology and Evolution
54. Loss of SETDB1-mediated H3K9me3 in human neural progenitor cells leads to transcriptional activation of L1 retrotransposons
    Ofelia Karlsson, Ninoslav Pandiloski, Vivien Horváth, Anita Adami, Raquel Garza, Pia Annette Johansson, Jonas Johansson, Christopher H. Douse, Johan Jakobsson · 2026 · Nucleic Acids Research
55. “Metabolic memory” of aging: anchoring, transmission, and frontiers of transgenerational intervention
    Yue Zhao · 2026 · Biogerontology
56. Engineered CRISPR-Cas systems for transcriptional regulation and precision molecular diagnostics: advances, challenges, and emerging microfluidic integration
    Iswarya Rambabu, Gomathy Baskar, Muath Suliman, Mοhd Saeed, Muthezhilan Radhakrishnan, Ranjith Balu, Thirunavukkarasu Palaniyandi · 2026 · Clinica Chimica Acta
57. CRISPR in clinical oncology: translational advances from molecular diagnostics to therapeutics
    Sam E. Grigg, Carolyn Shembrey, Mohamed Fareh, Piers A. Blombery, Jacob E. Corn, John Francis Seymour, Joshua M. L. Casan · 2026 · Nature Reviews Clinical Oncology
58. Genetic variants shape single-cell chromatin accessibility and disease risk
    Xue, Angli, Fan, Jianan, Dong, Oscar A., Huang, Hao Lawrence, Chen, Ling, Allen, Peter C., Spenceley, Eleanor, Sagi-Zsigmond, Eszter, Bowen, Blake, Henry, Albert et al. · 2026 · Nature
59. Advances in computational and experimental approaches for deciphering transcriptional regulatory networks
    Camille M. Moeckel, Ioannis Mouratidis, Nikol Chantzi, Yasin Uzun, Ilias Georgakopoulos‐Soares · 2024 · BioEssays
60. Deciphering and simulating models of radiation genotoxicity with CRISPR/Cas9 systems
    Dusan Vukmirovic, Colin B Seymour, Carmel E Mothersill · 2020 · Mutation Research/Reviews in Mutation Research
61. Chemotherapy suppresses SHH gene expression via a specific enhancer.
    Ya-Fei Zhang, Jian-Qiong Lin, Kai-Bin Yang, Zhi-Cao Yue · 2022 · Journal of genetics and genomics = Yi chuan xue bao
62. A Dual-Function “TRE-Lox” System for Genetic Deletion or Reversible, Titratable, and Near-Complete Downregulation of Cathepsin D
    Heather M. Terron, Derek S. Maranan, Luke A. Burgard, Frank M. LaFerla, Shelley Lane, Malcolm A. Leissring · 2023 · International Journal of Molecular Sciences
63. Retinoblastoma protein activity revealed by CRISPRi study of divergent Rbf1 and Rbf2 paralogs
    Ana‐Maria Raicu, Patricia Castanheira, David N. Arnosti · 2024 · G3 Genes Genomes Genetics
64. ChromActivity: integrative epigenomic and functional characterization assay based annotation of regulatory activity across diverse human cell types
    Tevfik Umut Dincer, Jason Ernst · 2025 · Genome biology
65. RUNX2 cooperates with SREBP1 to rewire cancer metabolism and promote aggressiveness
    Emanuele Vitale, Mila Gugnoni, Veronica Manicardi, Silvia Muccioli, Federica Torricelli, Benedetta Donati, Simonetta Piana, Gloria Manzotti, Elisa Salviato, Francesca Reggiani et al. · 2025 · Journal of Experimental & Clinical Cancer Research
66. Non-coding RNA therapy in cancer
    Kamila Součková, Tina Catela Ivković, Ondřej Slabý · 2019 · Elsevier eBooks
67. Key to Delivery: The (Epi-)genome Editing Vector Toolbox
    Sabrina Just, Hildegard Büning · 2018 · Methods in molecular biology
68. A guide to Understanding “State-of-the-Art” Basic Research Techniques in Anesthesiology
    D. Obal, Shao-Gen Wu, A. McKinstry-Wu, Vivianne L. Tawfik · 2020 · Anesthesia and Analgesia
69. Transgenic mice for in vivo epigenome editing with CRISPR-based systems
    Matthew P. Gemberling, Keith Siklenka, Erica Rodriguez, Katherine R. Tonn Eisinger, Alejandro Barrera, Fang Liu, Ariel Kantor, Liqing Li, Valentina Cigliola, Mariah F. Hazlett et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
70. Compatibility logic of human enhancer and promoter sequences
    Drew T. Bergman, T. Jones, Vincent Liu, Layla Siraj, Helen Kang, Joseph Nasser, Michael Kane, Tung H. Nguyen, Sharon R. Grossman, Charles P. Fulco et al. · 2021 · bioRxiv
71. A novel enhancer that regulates Bdnf expression in developing neurons
    Emily Brookes, Ho Yu Alan Au, Wazeer Varsally, Christopher Barrington, Suzana Hadjur, Antonella Riccio · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
72. Genetic and epigenetic driven variation in regulatory regions activity contribute to adaptation and evolution under endocrine treatment
    Neil Slaven, Rui Lopes, Eleonora Canale, Diana Ivanoiu, Claudia Pacini, Ines Amorim Monteiro Barbosa, Melusine Bleu, Sara Bravaccini, Sara Ravaioli, Maria Vittoria Dieci et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
73. HyperCas12a enables multiplexed CRISPRi screens
    Schuyler M. Melore, Christian McRoberts Amador, Marisa C. Hamilton, Charles A. Gersbach, Timothy E. Reddy · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
74. A Versatile Clustered Regularly Interspaced Palindromic Repeats Toolbox to Study Neurological CaV3.2 Channelopathies by Promoter-Mediated Transcription Control
    Despina Tsortouktzidis, Anna R. Tröscher, Herbert Schulz, Thoralf Opitz, Susanne Schoch, Albert J. Becker, Karen M. J. van Loo · 2022 · Frontiers in Molecular Neuroscience
75. Identification and characterization of putative enhancer regions that direct Il6 transcription in murine macrophages
    Norisuke Kano, Takeo Miki, Yurina Uehara, Daisuke Ori, Taro Kawai · 2024 · International Immunology
76. p62 mRNA suppresses NLRP1 expression in cutaneous SCC cells through miR-34a-5p
    Paulina Hennig, Patrick Turko, Michela Di Filippo, Mitchell Paul Levesque, Thomas M. Kündig, Hans‐Dietmar Beer · 2025 · Cell Death and Disease
77. Discovery of oligodendrocyte enhancers that regulate Sox10 expression
    Hongjoo An, Chuandong Fan, Dongkyeong Kim, Huy Bui, Yungki Park · 2025 · PLoS Genetics
78. Chamber-specific chromatin architecture guides functional interpretation of disease-associated Cis-regulatory elements in human cardiomyocytes
    S. Haydar, Rebecca Bednarz, Patrick Laurette, Izzatullo Sobitov, Núria Díaz i Pedrosa, Pavankumar Videm, T. Lueneburg, S. Kuß, H W Lahm, Martina Dreßen et al. · 2026 · Nature Communications
79. From chromatin to crop: epigenetic innovations in bioenergy systems
    Saddie Vela, Christina R. Steadman · 2026 · Frontiers in Plant Science
80. Next generation technologies for CRISPR-based epigenome and transcriptional modulation
    Rithu K. Pattali, Nikita S. Divekar, James K. Nuñez · 2026 · Current Opinion in Biomedical Engineering
81. Gene therapy for huntington’s disease: advances, challenges, and future perspectives
    Riya Kaushal, Mohit Yadav, Sourabh Kosey, Madhaw Dwivedi · 2026 · Neurogenetics
82. Gut microbiota modulation of regulatory DNA elements revealed by massively parallel functional characterization.
    Chadmirah Zaratiana, Y. M., Yong-An Lee, A. Ong, Tiffany Yi-Chen Liu, Suet-Mei Crystal Low, S. Chang, Shaun Tan, Dayang Nurul Asyiqin Mustafa, Adheet Ganesh et al. · 2026 · Molecules and Cells
83. Precision engineering for ocular gene therapy: Molecular tools, delivery platforms, and disease applications
    孔令芸, Changchang Xin, Mingrui Cheng, Shuangyu Ma, Zongli Zheng, Jia Chen, Xujiao Zhou · 2026 · Eye Discovery
84. Genetic Manipulation of the Embryonic Chicken Inner Ear
    Nicolas Daudet, Magdalena Żak, Thea P. Støle, Stephen J. Terry · 2022 · Neuromethods
85. CRISPRi-mediated knock-down of PRDM1/BLIMP1 programs central memory differentiation in ex vivo-expanded human T cells
    Mohammad Azadbakht, Ali Sayadmanesh, Naghme Nazer, Amirhossein Ahmadi, Sara Hemmati, Hoda Mohammadzade, Marzieh Ebrahimi, Hossein Baharvand, Babak Hossein Khalaj, Mahmoud Reza Aghamaali et al. · 2021 · Bioimpacts
86. Technological Convergence: Highlighting the Power of CRISPR Single-Cell Perturbation Toolkit for Functional Interrogation of Enhancers
    Mohammad Reza Eftekhariyan Ghamsari, Joseph Rosenbluh, A Vipin Menon, Nigel Hamilton Lovell, Hamid Alinejad-Rokny · 2023 · Cancers
87. Epigenetic control of multiple genes with a lentiviral vector encoding transcriptional repressors fused to compact zinc finger arrays
    Davide Monteferrario, Marion David, Satish Kumar Tadi, Yuanyue Zhou, Irène Marchetti, Caroline Jeanneau, Gaëlle Saviane, Coralie F Dupont, Angélique E. Martelli, Lynn N. Truong et al. · 2024 · Molecular Therapy — Methods & Clinical Development
88. Miniaturized Fab’ imaging probe derived from a clinical antibody: Characterization and imaging in CRISPRi-attenuated mammary tumor models
    Suresh Prasad Gupta, Rahul Pal, Eric J. Schmidt, Murali Krishnamoorthy, Anita M. Leporati, Anand T. N. Kumar, Alexei A. Bogdanov Jr · 2024 · iScience
89. Identification and characterization of an enhancer element regulating expression of Cdkn1c (p57 gene)
    Daisuke Koga, Shogo Nakayama, Tsunaki Higa, Keiichi I. Nakayama · 2024 · Genes to Cells
90. Intracrine VEGF Signaling Is Required for Adult Hippocampal Neural Stem Cell Maintenance and Vascular Proximity
    Tyler J. Dause, Robert Osap, Akela A. Kuwahara, Jiyeon K. Denninger, Elizabeth D. Kirby · 2025 · Molecular Neurobiology
91. Competitive rDNA binding by dCas9 induces outside-in disassembly of the nucleolus
    Xiaohui Yang, Shan Gao · 2025 · Biochemical and Biophysical Research Communications
92. Targeting the 3D genome by anthracyclines for chemotherapeutic effects
    Minkang Tan, Shengnan Sun, Yuchen Liu, Andrea A. Perreault, Douglas H. Phanstiel, Liping Dou, Baoxu Pang · 2025 · Proceedings of the National Academy of Sciences
93. Epigenetic Therapies in the Precision Medicine Era
    Michel Lopes Leite, Kamila Botelho Sampaio de Oliveira, Victor Albuquerque Cunha, Simoni Campos Dias, Nicolau Brito da Cunha, Fabrício Falconi Costa · 2020 · Advanced Therapeutics
94. CRISPR-Cas9 in cancer therapeutics
    Shubhchintan Randhawa · 2021 · Progress in molecular biology and translational science
95. Epigenome Editing
    Paul Enríquez · 2019 · IntechOpen eBooks
96. 4.32 Gene Editing Tools
    David Ede, Niloofar Farhang, Joshua D. Stover, Robby D. Bowles · 2017 · Elsevier eBooks
97. Forward and Reverse Genetics to Model Human Diseases in the Mouse
    Yoichi Gondo, Shigeru Makino, Ryutaro Fukumura · 2017 · Elsevier eBooks
98. Gene Therapy for Facioscapulohumeral Muscular Dystrophy (FSHD)
    Daniel G. Miller · 2019 · Springer eBooks
99. CRISPR/Cas9 technologies in epigenetics research
    John M. Schoelz, Nicole C. Riddle · 2020 · Elsevier eBooks
100. Silencing integrated SIV proviral DNA with TAR‐specific CRISPR tools
     Lisa M. Smith, Vida L Hodara, Laura M. Parodi, Jessica E. Callery, Luis David Giavedoni · 2020 · Journal of Medical Primatology